NASDAQ:HSICHenry Schein Stock Price, Forecast & News

$62.24

+2.67 (+4.48 %)

(As of 05/27/2020 04:00 PM ET)

Add

Compare

Today's Range

$60.23

Now: $62.24▼

$62.36

50-Day Range

$46.35

MA: $53.25▼

$57.78

52-Week Range

$41.85

Now: $62.24▼

$73.99

Volume2.05 million shs

Average Volume1.79 million shs

Market Capitalization$8.89 billion

P/E Ratio12.78

Dividend YieldN/A

Beta0.95

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.

Beat the Market (BTM) Rank^™

2.0 Analyst's Opinion

Consensus Rating
Henry Schein has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 3 buy ratings, 8 hold ratings, and 3 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $63.73, Henry Schein has a potential upside of 2.4% from its current price of $62.24.
Amount of Analyst Coverage
Henry Schein has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.8 Community Rank

Outperform Votes
Henry Schein has received 323 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Henry Schein has received 585 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Henry Schein has received 64.43% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote “Outperform” if you believe HSIC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HSIC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Henry Schein does not currently pay a dividend.
Dividend Growth
Henry Schein does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Henry Schein insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $406,920.00 in company stock.
Percentage Held by Insiders
Only 1.06% of the stock of Henry Schein is held by insiders.

3.1 Earnings and Valuation

Earnings Growth
Earnings for Henry Schein are expected to grow by 52.58% in the coming year, from $2.13 to $3.25 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Henry Schein is 12.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 14.70.
Price to Earnings Ratio vs. Sector
The P/E ratio of Henry Schein is 12.78, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.98.
Price to Earnings Growth Ratio
Henry Schein has a PEG Ratio of 4.32. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Henry Schein has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.39 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Medical & hospital equipment

Sub-IndustryHealth Care Distributors

SectorMedical

Current SymbolNASDAQ:HSIC

Previous Symbol

CUSIP80640710

CIK1000228

Webwww.henryschein.com

Phone631-843-5500

Debt

Debt-to-Equity Ratio0.29

Current Ratio1.64

Quick Ratio1.04

Price-To-Earnings

Trailing P/E Ratio12.78

Forward P/E Ratio29.22

P/E Growth4.32

Sales & Book Value

Annual Sales$9.99 billion

Price / Sales0.89

Cash Flow$5.30 per share

Price / Cash Flow11.74

Book Value$25.26 per share

Price / Book2.46

Profitability

EPS (Most Recent Fiscal Year)$3.51

Net Income$694.73 million

Net Margins7.11%

Return on Equity15.19%

Return on Assets7.44%

Miscellaneous

Employees19,000

Outstanding Shares142,756,000

Market Cap$8.89 billion

Next Earnings Date8/4/2020 (Estimated)

OptionableOptionable

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

How has Henry Schein's stock been impacted by COVID-19 (Coronavirus)?

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HSIC stock has increased by 7.9% and is now trading at $62.24. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Henry Schein?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Henry Schein.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Henry Schein.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, May, 5th. The company reported $0.94 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.74 by $0.20. The company had revenue of $2.43 billion for the quarter, compared to analysts' expectations of $2.32 billion. Henry Schein had a net margin of 7.11% and a return on equity of 15.19%. The company's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the business posted $0.80 earnings per share. View Henry Schein's earnings history.

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Henry Schein shares split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its board has approved a share buyback program on Thursday, October 31st 2019, which allows the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to buy up to 4.3% of its shares through open market purchases. Shares buyback programs are often an indication that the company's management believes its stock is undervalued.

What price target have analysts set for HSIC?

14 analysts have issued 12-month price objectives for Henry Schein's shares. Their forecasts range from $50.00 to $80.00. On average, they anticipate Henry Schein's stock price to reach $63.73 in the next year. This suggests a possible upside of 2.4% from the stock's current price. View analysts' price targets for Henry Schein.

Has Henry Schein been receiving favorable news coverage?

Media coverage about HSIC stock has been trending somewhat positive on Wednesday, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Henry Schein earned a news impact score of 1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutHenry Schein.

Who are some of Henry Schein's key competitors?

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI). View all competitors.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), AbbVie (ABBV), AT&T (T), Walt Disney (DIS), Pfizer (PFE), Intel (INTC), NVIDIA (NVDA), salesforce.com (CRM), Cisco Systems (CSCO) and UnitedHealth Group (UNH).

Who are Henry Schein's key executives?

Henry Schein's management team includes the following people:

Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 69)
Mr. James P. Breslawski, Vice Chairman & Pres (Age 65)
Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 62)
Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Director (Age 66)
Mr. Mark E. Mlotek, Exec. VP, Chief Strategic Officer & Director (Age 63)

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by many different institutional and retail investors. Top institutional shareholders include Longview Partners Guernsey LTD (10.22%), BlackRock Inc. (8.41%), State Street Corp (5.36%), Mackenzie Financial Corp (2.30%), Atlanta Capital Management Co. L L C (1.90%) and JPMorgan Chase & Co. (1.87%). Company insiders that own Henry Schein stock include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Mark E Mlotek, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel. View institutional ownership trends for Henry Schein.

Which major investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, APG Asset Management N.V., APG Asset Management N.V., APG Asset Management N.V., AMI Asset Management Corp, Boston Trust Walden Corp, Mackenzie Financial Corp, and Boston Trust Walden Corp. Company insiders that have sold Henry Schein company stock in the last year include E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Stanley M Bergman, Steven Paladino, and Walter Siegel. View insider buying and selling activity for Henry Schein.

Which major investors are buying Henry Schein stock?

HSIC stock was bought by a variety of institutional investors in the last quarter, including Sound Shore Management Inc. CT, BlackRock Inc., Fiduciary Management Inc. WI, AXA, Acadian Asset Management LLC, Bank of New York Mellon Corp, New York State Common Retirement Fund, and Nuveen Asset Management LLC. View insider buying and selling activity for Henry Schein.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $62.24.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $8.89 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

What is Henry Schein's official website?

The official website for Henry Schein is www.henryschein.com.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff